Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Platzbecker

Showing results (11-20 of 482) with videos related to

Pageof 49
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2020
Patient stratification in myelodysplastic syndromes: how a puzzle may become a mapAnne Sophie Kubasch, Uwe Platzbecker
Cancers|May 26, 2018
Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AMLAnne Sophie Kubasch, Uwe Platzbecker
Cells|August 26, 2022
How Azanucleosides Affect Myeloid Cell FateAnna Stein, Uwe Platzbecker, Michael Cross
Current Hematologic Malignancy Reports|September 7, 2016
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring SideroblastsAnna Mies, Olivier Hermine, Uwe Platzbecker
Haematologica|October 24, 2024
Treatment of lower-risk myelodysplastic syndromesAlmuth Maria Anni Merz, Uwe Platzbecker
Current Hematologic Malignancy Reports|July 2, 2015
Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?Martin Wermke, Silke Gloaguen, Uwe Platzbecker
British Journal of Haematology|October 1, 2019
How we manage adults with myelodysplastic syndromePierre Fenaux, Uwe Platzbecker, Lionel Ades
Hemasphere|July 11, 2020
Controversies on the Consequences of Iron Overload and Chelation in MDSFrancesca Vinchi, Saskia Hell, Uwe Platzbecker
Experimental Hematology|November 30, 2023
Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasmsAlmuth Maria Anni Merz, Uwe Platzbecker
Blood Advances|March 9, 2021
Development of luspatercept to treat ineffective erythropoiesisAnne Sophie Kubasch, Pierre Fenaux, Uwe Platzbecker
Pageof 49

Showing results (11-20 of 482) with videos related to

Sort By:
Pageof 49
Hematology. American Society of Hematology. Education Program|December 4, 2020
Patient stratification in myelodysplastic syndromes: how a puzzle may become a mapAnne Sophie Kubasch, Uwe Platzbecker
Cancers|May 26, 2018
Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AMLAnne Sophie Kubasch, Uwe Platzbecker
Cells|August 26, 2022
How Azanucleosides Affect Myeloid Cell FateAnna Stein, Uwe Platzbecker, Michael Cross
Current Hematologic Malignancy Reports|September 7, 2016
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring SideroblastsAnna Mies, Olivier Hermine, Uwe Platzbecker
Haematologica|October 24, 2024
Treatment of lower-risk myelodysplastic syndromesAlmuth Maria Anni Merz, Uwe Platzbecker
Current Hematologic Malignancy Reports|July 2, 2015
Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?Martin Wermke, Silke Gloaguen, Uwe Platzbecker
British Journal of Haematology|October 1, 2019
How we manage adults with myelodysplastic syndromePierre Fenaux, Uwe Platzbecker, Lionel Ades
Hemasphere|July 11, 2020
Controversies on the Consequences of Iron Overload and Chelation in MDSFrancesca Vinchi, Saskia Hell, Uwe Platzbecker
Experimental Hematology|November 30, 2023
Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasmsAlmuth Maria Anni Merz, Uwe Platzbecker
Blood Advances|March 9, 2021
Development of luspatercept to treat ineffective erythropoiesisAnne Sophie Kubasch, Pierre Fenaux, Uwe Platzbecker
Pageof 49